IMM 6.25% 30.0¢ immutep limited

fda ods approved, page-22

  1. 46 Posts.
    @ SamT21 - PRR made mention of the orphan drug status approval from the FDA for CVac in its investor updated released to the ASX on 13 September 2010. PRR left it to the last page (after the spiel about the management) of the investor update to actually inform the market about the approval. Guess it must not be that big a deal to PRR if they couldn't be bothered issuing a separate notice to the market.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.020(6.25%)
Mkt cap ! $435.7M
Open High Low Value Volume
31.5¢ 31.5¢ 29.5¢ $2.355M 7.796M

Buyers (Bids)

No. Vol. Price($)
8 128197 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 100000 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.